Investment history

Through Sagard I and Sagard II, Sagard enjoys much greater freedom of action than other funds, in particular to invest over longer periods – often more than five years – and to deploy a wider variety of financing solutions, from LBOs to minority stakes.

“I’m very pleased that Sagard has decided to take a significant stake in our company, which will enable us to leverage their experience and powerful networks. More importantly, it will give us the resources we need to fulfil our ambitious commitment to becoming a global industry leader.”

Marc Prikazsky
Chairman and Chief Executive Officer
Acquisition: 
2010
Activity: 
International veterinary pharmaceuticals company
Rev. (M€): 
485
Funds:
Sagard II
En savoir plus